7-Hydroxy-4-chromone

CAS No. 59887-89-7

7-Hydroxy-4-chromone( 7-Hydroxychromone | 7-hydroxy-4-benzopyrone )

Catalog No. M20749 CAS No. 59887-89-7

7-Hydroxychromone is a Src kinase inhibitor (IC50 of <300 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 35 In Stock
100MG 50 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-Hydroxy-4-chromone
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Hydroxychromone is a Src kinase inhibitor (IC50 of <300 μM).
  • Description
    7-Hydroxychromone is a Src kinase inhibitor (IC50 of <300 μM).
  • In Vitro
    7-Hydroxychromone (compound 8) is a 4-oxo-4H-1-benzopyran derivative which can inhibit Src kinase with an IC50 of <300 μM.
  • In Vivo
    ——
  • Synonyms
    7-Hydroxychromone | 7-hydroxy-4-benzopyrone
  • Pathway
    Tyrosine Kinase
  • Target
    Src
  • Recptor
    Src
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    59887-89-7
  • Formula Weight
    162.14
  • Molecular Formula
    C9H6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:150 mg/mL (925.13 mM)
  • SMILES
    Oc1ccc2c(c1)occc2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Marcus R K Burdette C Q . Determination of Isoflavone Content in Soy Red Clover and Kudzu Dietary Supplement Materials by Liquid Chromatography-Particle Beam/Electron Ionization Mass Spectrometry[J]. Journal of Aoac International 2013 96(5):-.
molnova catalog
related products
  • squarunkinA

    squarunkinA is a novel modulator of the UNC119-Cargo Interaction, potently and selectively inhibiting the binding of a myristoylated peptide representing the N-terminus of Src kinase to UNC119A

  • Tirbanibulin Mesylat...

    Tirbanibulin Mesylate is an inhibitor of Src that targets the peptide substrate site of Src.

  • KX2-391

    KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.